FDA official announcements or regulatory documents

Abbott Faces Trial on July 8 Over Claims Similac Preterm Infant Formula Causes Dangerous Disease

Jul 8, 2024, 10:11 AM

Abbott, the maker of Similac baby formula, is set to face a trial on Monday, July 8, over allegations that its specialty formula for preterm infants causes a serious intestinal disease. This trial marks the second in a series of hundreds of similar lawsuits in the United States. The formula is used in neonatal intensive care units and is accused of causing a potentially deadly bowel disease. The case has seen nutrition companies and parents clash in court over the cause of the disease.